Skip to Content
GenesGenes
  • Article
  • Open Access

18 January 2023

13 Pages

KIF6 Trp719Arg Genetic Variant Increases Risk for Thoracic Aortic Dissection

,
,
,
,
,
,
,
and
1
Aortic Institute, Yale University School of Medicine, New Haven, CT 06510, USA
2
Department of Statistics, Rowan University, Glassboro, NJ 08028, USA
3
Department of Statistics, Stony Brook University, Stony Brook, NY 11794, USA
4
DNA Diagnostics Laboratory, Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA
This article belongs to the Section Human Genomics and Genetic Diseases

Abstract

Background: KIF6 (kinesin family member 6), a protein coded by the KIF6 gene, serves an important intracellular function to transport organelles along microtubules. In a pilot study, we found that a common KIF6 Trp719Arg variant increased the propensity of thoracic aortic aneurysms (TAA) to suffer dissection (AD). The present study aims for a definite investigation of the predictive ability of KIF6 719Arg vis à vis AD. Confirmatory findings would enhance natural history prediction in TAA. Methods: 1108 subjects (899 aneurysm and 209 dissection patients) had KIF6 719Arg variant status determined. Results: The 719Arg variant in the KIF6 gene correlated strongly with occurrence of AD. Specifically, KIF6 719Arg positivity (homozygous or heterozygous) was substantially more common in dissectors (69.8%) than non-dissectors (58.5%) (p = 0.003). Odds ratios (OR) for suffering aortic dissection ranged from 1.77 to 1.94 for Arg carriers in various dissection categories. These high OR associations were noted for both ascending and descending aneurysms and for homozygous and heterozygous Arg variant patients. The rate of aortic dissection over time was significantly higher for carriers of the Arg allele (p = 0.004). Additionally, Arg allele carriers were more likely to reach the combined endpoint of dissection or death (p = 0.03). Conclusions: We demonstrate the marked adverse impact of the 719Arg variant of the KIF6 gene on the likelihood that a TAA patient will suffer aortic dissection. Clinical assessment of the variant status of this molecularly important gene may provide a valuable “non-size” criterion to enhance surgical decision making above and beyond the currently used metric of aortic size (diameter).

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.